Rice Steven J. 4
4 · Vir Biotechnology, Inc. · Filed Feb 24, 2022
Insider Transaction Report
Form 4
Rice Steven J.
Chief Administrative Officer
Transactions
- Award
Common Stock
2022-02-22+20,000→ 38,658 total - Award
Stock Option (Right to Buy)
2022-02-22+40,000→ 40,000 totalExercise: $29.48Exp: 2032-02-21→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter.